.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
QuintilesIMS
Cerilliant
Teva
Julphar
Boehringer Ingelheim
Deloitte
Moodys
Mallinckrodt

Generated: December 14, 2017

DrugPatentWatch Database Preview

Aurobindo Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARM, and what generic and branded alternatives to AUROBINDO PHARM drugs are available?

AUROBINDO PHARM has two hundred and eighty-six approved drugs.

There are thirty-four tentative approvals on AUROBINDO PHARM drugs.

Summary for Aurobindo Pharm

US Patents:0
Tradenames:227
Ingredients:203
NDAs:286
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LtdALBUTEROL SULFATEalbuterol sulfateSOLUTION;INHALATION206224-001Oct 17, 2017ANRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdAMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDEamlodipine besylate; benazepril hydrochlorideCAPSULE;ORAL202239-006Sep 5, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdARIPIPRAZOLEaripiprazoleTABLET;ORAL203908-004Oct 8, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION202600-001Dec 21, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdALPRAZOLAMalprazolamTABLET, EXTENDED RELEASE;ORAL090871-004Jun 7, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdCITALOPRAM HYDROBROMIDEcitalopram hydrobromideSOLUTION;ORAL077812-001Aug 28, 2006AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdLAMIVUDINE AND ZIDOVUDINElamivudine; zidovudineTABLET;ORAL077558-001May 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdLAMIVUDINElamivudineTABLET;ORAL077464-002Nov 21, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaHYDROCHLOROTHIAZIDEhydrochlorothiazideCAPSULE;ORAL078164-001Sep 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdFAMCICLOVIRfamciclovirTABLET;ORAL091114-002Mar 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for AUROBINDO PHARM drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazoleDelayed-release Tablets20 mgOMEPRAZOLE6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Daiichi Sankyo
Argus Health
Harvard Business School
UBS
Baxter
Accenture
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot